talazoparib,atezolizumab
pfizer,roche
['lung', 'biomarker', 's1929', 'sclc']
lci s : the phase ii trial s1929 presented saturday shows promising results for small cell lung cancer patients. this landmark study shows the benefits of using a biomarker in #sclc treatments, paving the way for novel treatments. #asco23 
Levine Cancer Institute is home to top providers, cutting-edge treatments and groundbreaking clinical trials. Our expert care helps patients heal – and thrive.